Targeting Anti-Cancer Active Compounds: Affinity-Based Chromatographic Assays
- PMID: 27306095
- PMCID: PMC5154774
- DOI: 10.2174/1381612822666160614080506
Targeting Anti-Cancer Active Compounds: Affinity-Based Chromatographic Assays
Abstract
Affinity-based chromatography assays encompass the use of solid supports containing immobilized biological targets to monitor binding events in the isolation, identification and/or characterization of bioactive compounds. This powerful bioanalytical technique allows the screening of potential binders through fast analyses that can be directly performed using isolated substances or complex matrices. An overview of the recent researches in frontal and zonal affinity-based chromatography screening assays, which has been used as a tool in the identification and characterization of new anti-cancer agents, is discussed. In addition, a critical evaluation of the recently emerged ligands fishing assays in complex mixtures is also discussed.
Conflict of interest statement
The authors confirm that this article content has no conflict of interest.
Figures





References
-
- Stepanenko AA, Dmitrenko VV. Pitfalls of the MTT assay: Direct and off-target effects of inhibitors can result in over/underestimation of cell viability. Gene. 2015;574:193–203. - PubMed
-
- NIH - National Cancer Institute - Targeted Cancer Therapies. 2016
-
- de Moraes MC, Vanzolini KL, Cardoso CL, Cass QB. New trends in LC protein ligand screening. J Pharm Biomed Anal. 2014;87:155–166. - PubMed
-
- Cardoso CL, de Moraes MC, Cass QB. Immobilization of the Enzymes on Chromatographic Supports: A Tool to Research of Inhibitor Compounds. Quimica Nova. 2009;32:175–187.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources